IGMPI is conferred with ASSOCHAM Services Excellence Award 2017: Our Directors Mr Syed S. Abbas & Mrs Rafat Abedi, Chief Advisor Dr Mahesh Gupta, Advisor Mr Amitabh Srivastava are being honoured by the Chief Guest & Honorable Member of Parliament Dr. Udit Raj

 Recipient of QCI - D.L. Shah National Quality Award

Recipient of QCI - D.L. Shah National Quality Award

Targeting to fill up the gap between the existing and accessible knowledge

Targeting to fill up the gap between the existing and accessible knowledge

 

Flawed Study Designs in Clinical Trial Study leads to Confounding End-Points

Flawed Study Designs in Clinical Trial Study leads to Confounding End-Points

Director, FDA John Whyte stated in a research study that pharmaceutical industry miss on grasping patient centricity as they are not choosing clinically meaningful trial outcomes. He suggested that biopharmaceutical industry needs to “better listen to patients, rather than talking at them.”

He emphasized that patient conversation is very important in identifying preliminary research outcomes. According to a research study, 152,000 unique conversations between asthma patients from February 2006 through June 2017 revealed startling insights. For example: as per research approach, the most common topic of discussion with asthma patients includes lung and respiratory infections. However, the study exhibits that allergies, medications, and walking are topics of interest between patients.The study indicates that patients are discussing allergy related topics including rhinitis, and hay fever.

The studies emphasize the need to use aggregate technology in order to provide optimized study end‑points. The process of discussing strategies with patients before a study start-up will automatically result in a better study design. The table below shows best fit conversations among patient.

2843542977a8008ad5fca7ff543896f5rrrrrrrrrrrrrrr